UIM
REGN icon

USS Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History

USS Investment Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15.6M Buy
20,230
+915
+5% +$701K 0.06% 164
2025
Q4 		$14.9M Buy
19,315
+1,035
+6% +$703K 0.07% 156
2025
Q3 		$10.3M Hold
18,280
– – 0.05% 218
2025
Q2 		$9.59M Buy
18,280
+78
+0.4% +$43.5K 0.06% 216
2025
Q1 		$11.5M Hold
18,202
– – 0.08% 171
2024
Q4 		$13M Sell
18,202
-1,440
-7% -$1.21M 0.09% 177
2024
Q3 		$20.7M Sell
19,642
-282
-1% -$314K 0.15% 119
2024
Q2 		$21M Buy
19,924
+398
+2% +$386K 0.17% 100
2024
Q1 		$18.8M Buy
19,526
+402
+2% +$382K 0.15% 121
2023
Q4 		$16.8M Sell
19,124
-889
-4% -$732K 0.15% 124
2023
Q3 		$16.5M Buy
20,013
+857
+4% +$674K 0.18% 116
2023
Q2 		$13.8M Buy
19,156
+253
+1% +$195K 0.16% 132
2023
Q1 		$15.5M Buy
18,903
+337
+2% +$254K 0.21% 104
2022
Q4 		$13.4M Buy
18,566
+358
+2% +$264K 0.19% 121
2022
Q3 		$12.6M Sell
18,208
-5,344
-23% -$3.36M 0.18% 121
2022
Q2 		$13.9M Sell
23,552
-1,577
-6% -$1.03M 0.14% 155
2022
Q1 		$17.6M Buy
25,129
+877
+4% +$555K 0.14% 148
2021
Q4 		$15.3M Hold
24,252
– – 0.12% 173
2021
Q3 		$14.7M Buy
24,252
+18,204
+301% +$11.3M 0.12% 168
2021
Q2 		$3.38M Hold
6,048
– – 0.03% 330
2021
Q1 		$2.86M Hold
6,048
– – 0.02% 344
2020
Q4 		$2.92M Sell
6,048
-700
-10% -$378K 0.03% 312
2020
Q3 		$3.78M Hold
6,748
– – 0.04% 259
2020
Q2 		$4.21M Buy
+6,748
New +$3.83M 0.04% 226

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

USS Investment Management's REGN Position: Q1 2026 in Review

USS Investment Management increased its Regeneron Pharmaceuticals (REGN) stake by 4.7% in Q1 2026, buying an estimated $701K and bringing the position to 20,230 shares worth $15.6M. The position accounts for 0.06% of the portfolio, ranked #164.

USS Investment Management first reported a position in REGN in Q2 2020 and has held it in 24 quarters since. The position peaked at $21M in Q2 2024. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • USS Investment Management held 20,230 shares of Regeneron Pharmaceuticals worth $15.6M as of Q1 2026.
  • USS Investment Management bought 915 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $701K.
  • Regeneron Pharmaceuticals made up 0.06% of USS Investment Management's portfolio in Q1 2026, its #164 holding.
  • USS Investment Management first reported a position in Regeneron Pharmaceuticals in Q2 2020 and has held it in 24 quarters since.
  • USS Investment Management's Regeneron Pharmaceuticals position peaked at $21M in Q2 2024.
  • 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on USS Investment Management's 13F filing for Q1 2026, filed 24 Apr 2026.